Shu Xia
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Lung Cancer Treatments and Mutations 5
- Occupational and environmental lung diseases 3
- Co-authors
- Liang Wang (7 shared papers)Rachel L. Dittmar (6 shared papers)Meijun Du (7 shared papers)Tiezheng Yuan (6 shared papers)Xiaoyi Huang (3 shared papers)Stephen N. Thibodeau (3 shared papers)Debashis Nandy (2 shared papers)William A. See (2 shared papers)
- Journals
- Frontiers in Molecular Biosciences (3 papers)Cancer Research (2 papers)Supportive Care in Cancer (2 papers)Signal Transduction and Targeted Therapy (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shu Xia
53 papers receiving 1.3k citations
Shu Xia's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 516
- Molecular Medicine 103
- Endocrinology 54
- Pulmonary and Respiratory Medicine 287
- Molecular Biology 597
Countries citing papers authored by Shu Xia
This map shows the geographic impact of Shu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xia more than expected).
Fields of papers citing papers by Shu Xia
This network shows the impact of papers produced by Shu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xia. The network helps show where Shu Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer Hit paper breakdown → | 2014 | 566 |
| 2 | 2014 | 65 | |
| 3 | 2017 | 49 | |
| 4 | 2017 | 47 | |
| 5 | 2014 | 46 | |
| 6 | 2015 | 40 | |
| 7 | 2015 | 38 | |
| 8 | 2021 | 33 | |
| 9 | 2013 | 26 | |
| 10 | 2020 | 25 | |
| 11 | 2022 | 20 | |
| 12 | 2012 | 20 | |
| 13 | 2013 | 19 | |
| 14 | 2019 | 18 | |
| 15 | 2017 | 18 | |
| 16 | 2024 | 17 | |
| 17 | 2020 | 15 | |
| 18 | 2021 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2021 | 12 |
About Shu Xia
Shu Xia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Physiology, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers), Asthma and respiratory diseases (4 papers), Allergic Rhinitis and Sensitization (4 papers), Pain Mechanisms and Treatments (3 papers) and Occupational and environmental lung diseases (3 papers). The work is most often cited by research in Cancer Research (516 citations), Molecular Medicine (103 citations), Endocrinology (54 citations), Pulmonary and Respiratory Medicine (287 citations) and Molecular Biology (597 citations). Shu Xia has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Liang Wang, Rachel L. Dittmar, Meijun Du, Tiezheng Yuan, Xiaoyi Huang, Stephen N. Thibodeau, Debashis Nandy, William A. See, Manish Kohli and Winston Tan. Their work appears in journals such as Frontiers in Molecular Biosciences, Cancer Research, Supportive Care in Cancer, Signal Transduction and Targeted Therapy and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.